| Carol B Thompson, MD | |
|
3475 Richmond Rd Ste 200, Lexington, KY 40509-2500 | |
| (859) 296-4400 | |
| Not Available |
| Full Name | Carol B Thompson |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 12 Years |
| Location | 3475 Richmond Rd Ste 200, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316206584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | R3056 (Kentucky) | Secondary |
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 48856 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| John L. Buker, M.d., Psc | 7113813932 | 7 |
News Archive
Hearing loss is the third most common chronic illness for older adults. It can impact everyday life and can significantly affect a person's health and safety if gone untreated. Hearing aids are the most common treatment for hearing loss. However, in 2005 more than 325,000 hearing aids, less than four years old were unused according to a previous study in the Hearing Journal.
After surviving acute respiratory distress syndrome, a disease in which fluid begins to leak into the lungs of critically ill patients and makes it difficult to breathe, many patients develop mental illness.
A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine.
Researchers at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) announced today the results of research which they believe marks a significant advance in understanding how cardiac-specific genes are turned on during the development of the heart in mice embryos.
Sol-Gel Technologies announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Sol-Gel's Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea. This IND allows Sol-Gel to initiate Phase II studies with DER45-EV Gel in rosacea patients.
› Verified 4 days ago
| Entity Name | John L. Buker, M.d., Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114197803 PECOS PAC ID: 7113813932 Enrollment ID: O20040226000997 |
News Archive
Hearing loss is the third most common chronic illness for older adults. It can impact everyday life and can significantly affect a person's health and safety if gone untreated. Hearing aids are the most common treatment for hearing loss. However, in 2005 more than 325,000 hearing aids, less than four years old were unused according to a previous study in the Hearing Journal.
After surviving acute respiratory distress syndrome, a disease in which fluid begins to leak into the lungs of critically ill patients and makes it difficult to breathe, many patients develop mental illness.
A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine.
Researchers at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) announced today the results of research which they believe marks a significant advance in understanding how cardiac-specific genes are turned on during the development of the heart in mice embryos.
Sol-Gel Technologies announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Sol-Gel's Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea. This IND allows Sol-Gel to initiate Phase II studies with DER45-EV Gel in rosacea patients.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carol B Thompson, MD 3475 Richmond Rd Ste 200, Lexington, KY 40509-2500 Ph: (859) 296-4400 | Carol B Thompson, MD 3475 Richmond Rd Ste 200, Lexington, KY 40509-2500 Ph: (859) 296-4400 |
News Archive
Hearing loss is the third most common chronic illness for older adults. It can impact everyday life and can significantly affect a person's health and safety if gone untreated. Hearing aids are the most common treatment for hearing loss. However, in 2005 more than 325,000 hearing aids, less than four years old were unused according to a previous study in the Hearing Journal.
After surviving acute respiratory distress syndrome, a disease in which fluid begins to leak into the lungs of critically ill patients and makes it difficult to breathe, many patients develop mental illness.
A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine.
Researchers at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) announced today the results of research which they believe marks a significant advance in understanding how cardiac-specific genes are turned on during the development of the heart in mice embryos.
Sol-Gel Technologies announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Sol-Gel's Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea. This IND allows Sol-Gel to initiate Phase II studies with DER45-EV Gel in rosacea patients.
› Verified 4 days ago
Charlie Becknell, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 250 Fountain Ct, Lexington, KY 40509 Phone: 859-263-4444 Fax: 859-254-1814 | |
Leigh Ann Carter Beard, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 715 Shaker Dr Ste 132, Lexington, KY 40504 Phone: 859-288-5004 Fax: 859-288-5007 | |
Dr. Dana Black, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3475 Richmond Rd, Suite 200, Lexington, KY 40509 Phone: 859-296-4400 Fax: 859-296-4300 | |
Dr. Sean A Marzolf, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 250 Fountain Ct, Lexington, KY 40509 Phone: 859-263-4444 Fax: 859-263-6781 | |
Dr. Tandy Sutton Repass, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3475 Richmond Rd Ste 200, Lexington, KY 40509 Phone: 859-296-4400 | |
Dr. Clifton Smith, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 177 Burt Rd, Lexington, KY 40503 Phone: 859-276-1511 Fax: 859-276-3373 | |
Deborah K Phillips, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4071 Tates Creek Centre Dr Ste 202, Lexington, KY 40517 Phone: 859-226-0206 |